关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nicpbp.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  2 5 8 8 1 0 2 位浏览者
您当前的位置:首页 >> 正文

化学口服固体制剂仿制药质量和疗效一致性评价研究思考

Study on quality and efficacy consistency evaluation of chemical oral solid generic drugs

作者(英文):
分类号:R917
出版年·卷·期(页码):2018,38 (4):575-581
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

仿制药质量的差异直接影响群众用药的安全性和有效性。为整体提升我国药品质量水平,《国家药品安全“十二五”规划》(国发〔2012〕5号)明确提出把全面提高仿制药质量作为一项重要任务。本文梳理了化学普通口服固体制剂仿制药质量和疗效一致性评价研究的重点,主要从参比制剂、药学研究和体内研究等方面进行阐述,以期为我国仿制药质量和疗效一致性评价工作提供参考。

-----英文摘要:---------------------------------------------------------------------------------------

The medication safety and efficacy of the masses are directly influenced by the variable quality of generic drugs.To improve the quality of generics,the Nation Program for Drug Safety ‘12th Five-Year Plan’ had clearly proposed enhancing the quality of generic drugs and undertaking the generic drugs consistency evaluation.This article investigates the research focus of the quality and efficacy consistency evaluation of chemical oral solid generic drugs,including the selection of reference preparations,pharmaceutical research and in vivo studies in the consistency evaluation of generic drug.

-----参考文献:---------------------------------------------------------------------------------------
[1] 白毅.仿制药一致性评价应关注哪些"点"[N].中国医药报,2016-03-22(006) BAI Y.The point of consistency assessment of generic drugs[N].China Pharmaceutical News,2016-03-22(006)
[2] 国家食品药品监督管理总局.总局关于发布普通口服固体制剂参比制剂选择和确定等3个技术指导原则的通告(2016年第61号)[EB/OL].[2016-03-18].http://www.sda.gov.cn/WS01/CL0087/147583.html China Food and Drug Administration.The 3 Guidance for General Oral Solid Preparations Reference Preparation Selection and Determination[EB/OL].[2016-03-18].http://www.sda.gov.cn/WS01/CL0087/147583.html
[3] 杜冠华.保障药品安全与提高药品质量问题探讨[J].医药导报,2013,32(2):135 DU GH.Discussion on guaranteeing drug safety and improving drug quality[J].Her Med,2013,32(2):135
[4] 蔡仲曦,干荣富.药物一致性评价实施与药用辅料关联审评的探讨[J].上海医药,2017,38(5):3 CAI ZX,GAN RF.Study on the relationship between drug re-evaluation and pharmaceutical excipients[J].Shanghai Med Pharm,2017,38(5):3
[5] 杜冠华,吕扬.药物质量标准研究与药物质量控制[J].食品与药品,2008,10(5):1 DU GH,LU Y.The study of drug quantity and the control of drug effects[J].Foods Drugs,2008,10(5):1
[6] 杜冠华,吕扬.固体化学药物的优势药物晶型[J].中国药学杂志,2010,45(1):5 DU GH,LÜ Y.Optimal drug crystal form of solid pharmaceutic chemicals[J].Chin Pharm J,2010,45(1):5
[7] 王晋,张汝华,孙淑英.尼莫地平多晶型的研究[J].药学学报,1995,30(6):443 WANG J,ZHANG RH,SUN SY.Study on the polymorphism of nimodipine[J].Acta Pharm Sin,1995,30(6):443
[8] 袁恒杰,陈大为,刘艳丽,等.尼莫地平多晶型家兔体内药动学研究[J].中国药学杂志,2005,40(8):609 YUAN HJ,CHEN DW,LIU YL,et al.Study on pharmacokinetics of nimodipine polymorphs in rabbits[J].Chin Pharm J,2005,40(8):609
[9] 杜冠华,吕扬.仿制药一致性评价相关药物晶型的问题分析[J].医药导报,2017,36(6):593 DU GH,LÜ Y.Discussion on polymorphs in the consistency assessment of generic drugs[J].Her Med,2017,36(6):593
[10] 李雪梅,张哲峰.我国仿制药杂质研究中常见问题分析[J].中国新药杂志,2015,24(8):865 LI XM,ZHANG ZF.Analysis of common problems in the impurity research of chemical generics in China[J].Chin J New Drugs,2015,24(8):865
[11] 周立春.仿制药一致性评价中有关物质研究的思考[J].药学进展,2016,40(12):924 ZHOU LC.Reflections on the research of related substances in consistency evaluation for generic drugs[J].Prog Pharm Sci,2016,40(12):924
[12] 郝杰,张哲峰,毕小平.原料药杂质研究与控制浅析[J].中国现代应用药学,2015,32(6):757 HAO J,ZHANG ZF,BI XP.Analysis of method for testing and controlling the impurity of crude drug[J].Chin J Mod Appl Pharm,2015,32(6):757
[13] 杨劲博.体外溶出在质量控制中的作用[N].中国医药报,2017-01-10(006) YANG JB.In vitro dissolution in the role of quality control[N].China Pharmaceutical News,2017-01-10(006)
[14] 国家食品药品监督管理总局.普通口服固体制剂溶出度试验技术指导原则[EB/OL].[2015-02-05].http://www.sda.gov.cn/WS01/CL1757/114288.html China Food and Drug Administration.The Guidance for Dissolution Test Technique of Common Oral Solid Preparation[EB/OL].[2015-02-05].http://www.sda.gov.cn/WS01/CL1757/114288.html
[15] 王昕,唐素芳.吲达帕胺片体外溶出度试验与体内药代动力学的相关性[J].药物分析杂志,2013,33(5):755 WANG X,TANG SF.Investigation on in vitro dissolution of indapamide tablets and its relationship with the in vivo pharmacokinetics[J].Chin J Pharm Anal,2013,33(5):755
[16] 朱强,邓蓝进,陈永建,等.盐酸多奈哌齐口崩片的溶出曲线相似性研究[J].中南药学,2015,13(5):487 ZHU Q,DENG LJ,CHEN YJ,et al.Dissolution similarity of donepezil hydrochloride orally disintegrated tablets[J].Cent South Pharm,2015,13(5):487
[17] 姜雄平,魏立平.一种新的溶出曲线比较方案[J].药物分析杂志,2010,30(6):1026 JIANG XP,WEI LP.New comparative evaluation for dissolution profiles[J].Chin J Pharm Anal,2010,30(6):1026
[18] 熊亚群,李兰,刘雁鸣.阿莫西林胶囊溶出曲线相似性评价[J].中国药物评价,2015,32(2):65、XIONG YQ,LI L,LIU YM.Comparability evaluation of dissolution curve of amoxicillin capsules[J].Chin J Drug Eval,2015,32(2):65
[19] O'HARA T,DUNNE A,BUTLER J,et al.A review of methods used to compare dissolution profile data[J].Pharm Sci Technol Today,1998,1(5):214
[20] 杜超,王阳.六种释放曲线相似性评价方法在非洛地平缓释片中的应用比较[J].中国药剂学杂志,2013,11(4):78 DU C,WANG Y.Comparison and application of six similarity evaluation methods of release profiles in felodipine sustained release tablets[J].Chin J Pharm,2013,11(4):78
[21] 王昕,唐素芳,高立勤.溶出曲线相似性的两种评价方法[J].天津药学,2011,23(1):53 WANG X,TANG SF,GAO LQ.Two methods for evaluating the similarity of dissolution curve[J].Tianjin Pharm,2011,23(1):53
[22] 李冰,余煊强.美国仿制药生物等效性评价的意义及方法[J].中国处方药,2009(1):47 LI B,YU XQ.Significance and method of bioequivalence evaluation of american generic drugs[J].J China Prescr Drug,2009(1):47
[23] 施孝金.《以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则》解读[J].上海医药,2016,37(7):16 SHI XJ.Interpretation of the technical guidelines for the bioequivalence study of generic chemical drugs with pharmacokinetics parameters as the final evaluation index[J].Shanghai Med Pharm,2016,37(7):16
[24] 朱蕾蕾,李辰,张逸凡,等.盐酸美金刚片的人体生物等效性研究[J].药学服务与研究,2015,15(6):432 ZHU LL,LI C,ZHANG YF,et al.Bioequivalence of memantine hydrochloride tablets in healthy volunteers[J].Pharm Care Res,2015,15(6):432
[25] 王晓芳,郝光涛,张媛媛,等.青蒿琥酯片在健康人体中的生物等效性研究[J].中南药学,2016,14(2):13 WANG XF,HAO GT,ZHANG YY,et al.Bioequivalence research of artesunate tablets in healthy Chinese volunteers[J].Cent South Pharm,2016,14(2):138
[26] 国家食品药品监督管理总局.总局发布《人体生物等效性试验豁免指导原则(征求意见稿)》[EB/OL].[2016-04-08].http://www.sda.gov.cn/WS01/CL1757/149640.html China Food and Drug Administration.Human Bioequivalence Test Waiver Guidelines (Draft)[EB/OL].[2016-04-08].http://www.sda.gov.cn/WS01/CL1757/149640.html
[27] Food and Drug Administration.Guidance for Industry Bioequivalence Recommendations for Specific Products[EB/OL].(2010-06-10)[2016-12-26].https://www.fda.gov/downloads/drugs/guidancecompliancereg-ulatoryinformation/guidances/ucm072872.pdf
[28] 杨丹,马超,陈欣怡,等.仿制药质量与疗效一致性评价的生物豁免原则及各国及国际组织的生物等效性豁免品种[J].药物评价研究,2017,40(2):157 YANG D,MA C,CHEN XY,et al.Principles of biowaiver about the consistency evaluation of generic drug products and varieties of biowaiver in countries and international organizations[J].Drug Eval Res,2017,40(2):157
[29] 国家食品药品监督管理总局.推进仿制药一致性评价提升行业发展水平-仿制药质量和疗效一致性评价有关政策解读[EB/OL].[2016-09-14].http://www.sda.gov.cn/WS01/CL1749/164419.html China Food and Drug Administration.Promote the Consistency Assessment of Generic Drugs to Enhance the Level of Development of the Industry-Interpretation of Relevant Policies of the Consistency Evaluation of Generic Drug[EB/OL].[2016-09-14].http://www.sda.gov.cn/WS01/CL1749/164419.html

欢迎阅读《药物分析杂志》!您是该文第 602位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号
邮政编码:100050; 技术支持:010-60213898

电子邮件:ywfx@nicpbp.org.cn